Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Acute Lung Injury D055371 33 associated lipids
Mucositis D052016 7 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Atherosclerosis D050197 85 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Hyperuricemia D033461 4 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Fetal Weight D020567 12 associated lipids
Stroke D020521 32 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Migraine without Aura D020326 1 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Venous Thrombosis D020246 11 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Schaefer MB et al. Peroxisome proliferator-activated receptor-alpha reduces inflammation and vascular leakage in a murine model of acute lung injury. 2008 Eur. Respir. J. pmid:18653653
Samanta U and Bahnson BJ Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis. 2008 J. Biol. Chem. pmid:18784071
Beuk RJ et al. Leucocyte and platelet adhesion in different layers of the small bowel during experimental total warm ischaemia and reperfusion. 2008 Br J Surg pmid:18720462
Konger RL et al. Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. 2008 Prostaglandins Other Lipid Mediat. pmid:18555720
Fang H et al. Toxoplasma gondii-derived heat shock protein 70 induces lethal anaphylactic reaction through activation of cytosolic phospholipase A2 and platelet-activating factor via Toll-like receptor 4/myeloid differentiation factor 88. 2008 Microbiol. Immunol. pmid:18667035
Sánchez FA et al. Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18708444
Leong HS et al. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor. 2008 J. Leukoc. Biol. pmid:17974709
Kostopanagiotou G et al. Acute lung injury in a rat model of intestinal ischemia-reperfusion: the potential time depended role of phospholipases A(2). 2008 J. Surg. Res. pmid:17981297
Si J et al. STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17947454
Zhang XP et al. The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge. 2008 Dig. Dis. Sci. pmid:17597411
Aomatsu K et al. Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases. 2008 Immunology pmid:17662043
Smith JC et al. Identification of lysophosphatidylcholine (LPC) and platelet activating factor (PAF) from PC12 cells and mouse cortex using liquid chromatography/multi-stage mass spectrometry (LC/MS3). 2008 Rapid Commun. Mass Spectrom. pmid:18937225
Kihara Y et al. Platelet-activating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso-PAFAT axis. 2008 J. Immunol. pmid:18802104
Wislet-Gendebien S et al. Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors. 2008 BMC Neurosci pmid:18808659
Kwasniewski FH et al. Small bowel injury associated to allergy is triggered by platelet-activating factor, mast cells, neutrophils and protected by nitric oxide. 2008 Int. Immunopharmacol. pmid:18182253
Chen Y et al. Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertension. 2008 World J. Gastroenterol. pmid:18186558
Hikiji H et al. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. 2008 Prog. Lipid Res. pmid:18187046
Zhang Q et al. UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. 2008 J. Invest. Dermatol. pmid:18200048
Lu YY et al. Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. 2008 World J. Gastroenterol. pmid:18205269
Nomura DK et al. Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. 2008 Toxicol. Appl. Pharmacol. pmid:18164358
O' Meara CM et al. Relationship between in vitro sperm functional tests and in vivo fertility of rams following cervical artificial insemination of ewes with frozen-thawed semen. 2008 Theriogenology pmid:18248736
Sakellariou M et al. Intravenous infusion of PAF affects ovulation, fertilization and preimplantation embryonic development in NZB x NZW F1 hybrid mice. 2008 Prostaglandins Other Lipid Mediat. pmid:18248752
Yuhki K et al. Prostaglandin I2 plays a key role in zymosan-induced mouse pleurisy. 2008 J. Pharmacol. Exp. Ther. pmid:18256172
Chia YC et al. Antiplatelet aggregation coumarins from the leaves of Murraya omphalocarpa. 2008 Molecules pmid:18259135
Kasperska-Zajac A et al. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. 2008 Inflammation pmid:18193345
Vadas P et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. 2008 N. Engl. J. Med. pmid:18172172
Burks AW Factoring PAF in anaphylaxis. 2008 N. Engl. J. Med. pmid:18172180
Menzies-Gow NJ et al. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses. 2008 Am. J. Vet. Res. pmid:18241016
Caprani A et al. Preliminary study of pulsed-electromagnetic fields effects on endothelial (HUVEC) cell secretions--modulation of the thrombo-hemorrhagic balance. 2008 Electromagn Biol Med pmid:19037787
Satoh K [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke]. 2008 Brain Nerve pmid:19069165
Hemetsberger R et al. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. 2008 Coron. Artery Dis. pmid:19005299
Knapp S et al. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. 2008 J. Immunol. pmid:18292574
Mullol J et al. Rupatadine in allergic rhinitis and chronic urticaria. 2008 Allergy pmid:18339040
Claud EC et al. Platelet-activating factor-induced chloride channel activation is associated with intracellular acidosis and apoptosis of intestinal epithelial cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18339705
Shindou H [Lysophospholipid acyltransferase and platelet-activating factor (PAF) biosynthetic enzyme]. 2008 Seikagaku pmid:18341030
Tsujimura Y et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. 2008 Immunity pmid:18342553
Patel MI et al. The arachidonic acid pathway and its role in prostate cancer development and progression. 2008 J. Urol. pmid:18343442
Frost BL et al. The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. 2008 Semin. Perinatol. pmid:18346533
Zhang Y et al. Glycosides from the bark of Adina polycephala. 2008 J. Nat. Prod. pmid:18303851
Tsuchiya R et al. Characterization of canine platelet activation induced by platelet activating factor (PAF). 2008 J. Vet. Med. Sci. pmid:18319579
Song W et al. Pyridinium alkaloid-coupled secoiridoids from the flower buds of Lonicera japonica. 2008 J. Nat. Prod. pmid:18321056
Shiva D et al. High dose of lipopolysaccharide pre-treatment prevents OVA-induced anaphylactic decreases in rectal temperature in the immunized mice. 2008 Immunol. Lett. pmid:18433880
Leary PJ et al. A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18441203
Cooper D et al. Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow. 2008 J. Leukoc. Biol. pmid:18372340
Bansal AS et al. Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. 2008 N. Engl. J. Med. pmid:18389523
Okamoto H and Kamatani N Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. 2008 N. Engl. J. Med. pmid:18389524
Torres MI and Rios A Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. 2008 World J. Gastroenterol. pmid:18395894
Kim HA et al. Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis. 2008 Immunology pmid:18397269
Berry KA et al. Effects of acrolein on leukotriene biosynthesis in human neutrophils. 2008 Chem. Res. Toxicol. pmid:19548361
Sreevidya CS et al. Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. 2008 Cancer Res. pmid:18483284